The industry subsectors analyzed include DNA sequencing instruments, long-read DNA sequencing, informatics, PCR, droplet digital PCR, CTC capture and detection and liquid biopsy. The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from Jan.
Key forces driving the market are enumerated. The report discusses several significant, large-scale research initiatives that contribute to cancer diagnostic development. The report also discusses, in-depth, various liquid biopsy platforms and how these compare with tissue-based testing. This report reviews the main next generation diagnostic technologies, including next generation sequencing (NGS), polymerase chain reaction (PCR), multiplex conventional, cell or extracellular vesicle capture and arrays/microfluidics. The market sizes for next generation cancer diagnostics are given for 2019, 2020 (estimated) and 2025 (forecasted). The scope of this report includes next generation diagnostic technologies, applications, industry subsegments, major funding initiatives, patents and companies. Market share analysis of the key companies of the industry, their strategic profiling, competitive landscape, and their detailed company profiles, including Abbott Laboratories, Illumina Inc., Myriad Genetics Inc., Qiagen NV, Oche Holding AG, and Thermo Fisher Scientific Inc.Details of the key initiatives and programs related to the next generation cancer diagnostics market.Discussion on factors affecting the market including cancer diagnostics needs, regulatory trends, industry structure, and patent statuses.Evaluation of current market trends, market size, market forecast, pipeline analysis of new products, and regulatory scenarios of the cancer diagnostics market.Discussion on arrays and microfluidics (LOAC) technologies, multiplex conventional technologies, next generation sequencing technology and polymerase chain reaction (PCR) technology.Analyses of the next generation cancer diagnostics market by cancer site, analysis purpose, analysis platform and region.Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025.An overview of the global market and technologies for next generation cancer diagnostics.22 data tables and 74 additional tables.
After the measurement is complete, the results are immediately displayed on the computer monitor for interpretation.The global market for next generation cancer diagnostics is expected to grow from $6.2 billion in 2020 to $16.7 billion by 2025 with a compound annual growth rate (CAGR) of 21.9% for the period of 2020-2025. The analysis covers more than 550 body objects such as nerves, muscles, joints, organs etc., as well as the thirteen organ systems. Based on this reaction pattern, valuable conclusions can be drawn about the energetic state and the functionality of the organs and organ systems. In less than ten minutes, the Global Diagnostics system automatically analyzes and records the patient’s energetic reaction pattern.Įach body part and every body system, whether healthy or diseased, has a specific reaction pattern to weak, external stimuli. It enables the practitioner to measure and visualize energetic structures of the body. The Global Diagnostic System uses an advanced method called “Vitalfeld” technology (German for ‘dynamic field technology’). The Global Diagnostics system can help a therapist to confirm lab results and find additional clues about the origin of certain symptoms and what areas the therapy needs to focus on. The therapist’s diagnosis is based on conventional lab results and imaging. It is important to mention at this point that the Global Diagnostics system is only a supplementary diagnostic tool. Global Diagnostics is designed to provide a comprehensive view of the organ systems to see how they are interacting with one another. When dealing with multiple complaints involving different organ systems, it is often a challenge to find which therapeutic intervention will support healing, and which may overwhelm the body, triggering a negative reaction. Conventional diagnostic methods may reveal important indicators of stressors to the body, but rarely detect the underlying disorders, which are preventing the body from healing.
0 kommentar(er)
